Document Detail


High-affinity [3H]6-nitroquipazine binding sites in rat brain.
MedLine Citation:
PMID:  1694774     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
6-Nitroquipazine is a very potent and selective inhibitor of neuronal 5-hydroxytryptamine (5-HT; serotonin) uptake. We have characterized the specific binding of [3H]6-nitroquipazine to rat brain membranes at 22 degrees C. The present results indicate the presence of a single saturable high-affinity binding component for [3H]6-nitroquipazine. Scatchard analysis revealed an apparent equilibrium dissociation constant (Kd) of 93.0 +/- 2.23 pM, and a maximal number of binding sites (Bmax) of 831.7 +/- 18.7 fmol/mg protein (mean +/- S.D., n = 4). The kinetically derived dissociation constant was 74.5 pM. [3H]6-Nitroquipazine binding was inhibited selectively by 5-HT uptake inhibitors, and a good correlation was demonstrated between the potency of various drugs to inhibit [3H]6-nitroquipazine binding and [3H]5-HT uptake. The highest densities of [3H]6-nitroquipazine binding were obtained in the hypothalamus and midbrain, intermediate binding was observed in the striatum, hippocampus, medulla oblongata and cortex, and the lowest binding was observed in the cerebellum. Lesioning of 5-HT neurons with p-chloroamphetamine resulted in a 72% reduction in [3H]6-nitroquipazine binding compared to controls. These results indicate that the binding site specifically labelled by [3H]6-nitroquipazine is associated with the neuronal 5-HT transporter complex. [3H]6-Nitroquipazine is an excellent radioligand for the study of the 5-HT uptake system.
Authors:
K Hashimoto; T Goromaru
Related Documents :
15814274 - Alkaloids from boophane disticha with affinity to the serotonin transporter in rat brain.
3918224 - Implication of acidic lipids in 5-hydroxytryptamine receptor mechanisms.
6974884 - Subsensitivity of serotonin receptors after long-term treatment of rats with fluoxetine.
3139864 - Putative selective 5-ht-2 antagonists block serotonin 5-ht-1c receptors in the choroid ...
15175304 - Structural basis for iron binding and release by a novel class of periplasmic iron-bind...
22373814 - Plexin-b3 interacts with eb-family proteins through a conserved motif.
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of pharmacology     Volume:  180     ISSN:  0014-2999     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  1990 May 
Date Detail:
Created Date:  1990-08-13     Completed Date:  1990-08-13     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  273-81     Citation Subset:  IM    
Affiliation:
Department of Radiopharmaceutical Chemistry, Faculty of Pharmacy, University of Fukuyama, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Binding Sites
Binding, Competitive / drug effects
Brain Chemistry / drug effects*
Hydroxyindoleacetic Acid / metabolism
Kinetics
Male
Membranes / drug effects,  metabolism
Nerve Endings / drug effects,  metabolism
Quinolines
Quipazine / analogs & derivatives*,  metabolism,  pharmacokinetics
Rats
Rats, Inbred Strains
Serotonin / metabolism
Serotonin Antagonists / metabolism*
p-Chloroamphetamine / pharmacology
Chemical
Reg. No./Substance:
0/Quinolines; 0/Serotonin Antagonists; 4774-24-7/Quipazine; 50-67-9/Serotonin; 54-16-0/Hydroxyindoleacetic Acid; 64-12-0/p-Chloroamphetamine; 77372-73-7/6-nitroquipazine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Release of substance P-like immunoreactivity from the vascularly perfused rat stomach.
Next Document:  Opioid inhibition of cholinergic transmission in the guinea-pig ileum is independent of intracellula...